Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study. - Wikidata - awgldk - TriplyDB

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

http://www.wikidata.org/entity/Q43937799

about

Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.Factors associated with mortality in patients with tuberculosis Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis.Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients--a retrospective cohort study.Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China.Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China.Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan.Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan.Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis.Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis (MDR- TB) Compared with Non-MDR-TB Infections in Peninsular Malaysia Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam.A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB.Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.First use of bedaquiline in a patient with XDR-TB in Singapore.Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis.Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.MDR-/XDR-TB management: what it was, current standards and what is ahead.Treatment outcomes of multidrug-resistant tuberculosis in Taiwan: tackling loss to follow-up.Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis.Detecting drug-resistant tuberculosis: the importance of rapid testing.Sputum Smear and Culture Conversion in Multidrug Resistance Tuberculosis Patients in Seven Districts of Central Gujarat, India: A Longitudinal Study.Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot Treatment Outcomes Associated with Multidrug-resistant Tuberculosis Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013

P2860

Q27013703-02FBF230-94B2-4F06-8F2D-4AD90331A57C Q28473126-1E54C8C4-8572-4225-95C0-5F4B997C29B6 Q28474035-8AE94A51-DA76-419D-B061-8AE7D1FCE317 Q28476110-53EBFBEB-3067-4C56-9BA9-488F862FFAEC Q28482730-5459CB08-AB39-4476-AA38-886FE01EE292 Q28487970-1384EAB8-CD6F-4741-8E6D-55E43201FB5B Q28554607-D471906C-EDC6-41B6-95E3-B4634B0CBE1D Q30840887-6DA85F7F-762B-4792-AF77-0D84E0A59A77 Q30988371-63CAAE2F-5843-4A3C-97B4-5D9C92D4F81D Q33561777-8B0335EF-3525-4E36-9B76-F8556134A045 Q33595284-FF0B2312-5E79-4675-857E-9FD3473E472A Q34290003-C150AAE9-980C-4254-A29D-E694EC078B9F Q34603793-C028A023-EAFA-432C-BB6C-43455CA6578F Q35033562-79A6AB33-0966-4069-86AD-C5FDE7B8BD87 Q35689437-E99D783A-6992-408D-84FA-1A4780782698 Q35805940-34FCD523-14DD-432E-8CCC-019565CB5E9A Q36131565-9A0AE22E-7A6E-483B-A042-A53E7A976BA6 Q36258757-3A4E24A8-2F0E-449E-B0F6-92AE81A42311 Q36261365-C782DAE3-53EA-4C73-A0F9-E970E00EBC72 Q36448646-1B6B73B9-1574-4D32-8EF2-7C2F0A3DAC52 Q36959143-3DE27AD7-AE87-4B7B-9853-91F77A8F0BE5 Q37204743-B2A29A24-DC01-4C2B-A4A7-827FC46690C1 Q37259517-B20EAA51-36A2-4BBA-8DC2-1C49CFC8F99E Q38226326-02CCCD07-4937-44D2-ACCC-AC49927D05AF Q38231137-F6658FB4-E2CB-434A-B617-7042956AC93B Q39780875-4C1D5D0A-473E-465E-9BDE-9B07887EB733 Q40522564-E57595DE-56B4-43D7-AC90-4E12BB5205E1 Q41362907-B9C60FCE-ECB5-4BD3-BFE3-045CA046829C Q41699273-9A0A9A5B-2B79-460B-9F88-22EFEB5527EB Q45126482-1B5F97E3-A0E8-4587-8ED8-51E3DB78B350 Q46225849-3AECE1AB-E9DE-40E1-BAB3-298A9F7E6150 Q46273107-8CCD29F8-3B28-4E31-B7B9-7F5AC77F2714 Q47638862-A87C85AE-4B2B-43CA-AAA3-D63A3CA0D727 Q50027379-6948CCA5-F8EB-4E09-8D5E-D84F6FEC92A7 Q51532520-7300EB6E-24CA-4071-B5E7-34CB006AD9FD Q55432287-1F58D889-5204-48C8-8BF4-F4EA80924077 Q57488988-46F40477-F398-4F6D-9742-E6DC317C37B3 Q57922788-048A2C7C-7AA6-4504-B127-CA270E089809 Q58723149-5CADCA3B-E1CB-4AB7-B1CD-61335D30CA91

P2860

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

http://www.wikidata.org/entity/Q43937799

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

@en

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

@nl

type

label

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

@en

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

@nl

prefLabel

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

@en

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

@nl

P1433

Q43937799-8063A6C2-5450-4AE1-92D3-EFF272CDDB3D

P1476

Q43937799-30791C89-A636-475E-B9D7-0D0DBD818C8A

P2093

Q43937799-0C42F52A-1CD1-4857-9C3A-841A5E271844

Q43937799-0E8DE9C8-D95F-4B76-B460-0D6E93E26278

Q43937799-5BC143D8-D592-41B6-B8F5-B35A4D13941C

Q43937799-6A6DEB60-C8DD-44ED-BA06-731F89CD5764

Q43937799-9D38BF52-D8A9-43CF-87FE-79DE431ABBEE

Q43937799-A314AAE9-DFB0-48B3-A3AF-3CF5765AF0B1

Q43937799-C7DCBAB9-AB70-4D09-9652-808DEF25B51B

Q43937799-FA9AEF0F-3382-4332-81B2-91DAE5C70D46

P304

Q43937799-65987571-9C54-4CC6-ADBD-AF46846A4633

P31

Q43937799-187BCDFA-44EA-449A-935D-2313293988A3

P356

Q43937799-BBB7BD34-709B-4B70-A0BD-298AD13B9046

P433

Q43937799-1EAB2137-819C-4BBE-9FC3-CFC7B96D14A8

P478

Q43937799-04D64BAB-7A38-456A-836B-ACEB35E45676

P577

Q43937799-14E04803-A5A7-4A6C-B381-21DB3F7EB67A

P5875

Q43937799-16DC92EF-DF42-4A1C-BBC7-F4E9CB3D40BF

P698

Q43937799-4AC0F89F-43C9-4514-9BA8-2010DB4E62B9

P921

Q43937799-78A78C12-8EA2-41C0-A149-4072FB5B0F97

Q43937799-91865F70-3423-482E-A1F7-8641AEB574B5

P356

09031936.06.00125705

P1433

European Respiratory Journal

P1476

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study.

@en

P2093

C-J Hsu

http://www.w3.org/2001/XMLSchema#string

C-Y Chiang

http://www.w3.org/2001/XMLSchema#string

D A Enarson

http://www.w3.org/2001/XMLSchema#string

J Suo

http://www.w3.org/2001/XMLSchema#string

K-J Bai

http://www.w3.org/2001/XMLSchema#string

M-C Yu

http://www.w3.org/2001/XMLSchema#string

R-M Huang

http://www.w3.org/2001/XMLSchema#string

T-P Lin

http://www.w3.org/2001/XMLSchema#string

P304

980-985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.06.00125705

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6947173

http://www.w3.org/2001/XMLSchema#string

P698

16837502

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance